{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:33:18Z","timestamp":1790926398484,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,2,3]],"date-time":"2013-02-03T00:00:00Z","timestamp":1359849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s10552-013-0156-6","type":"journal-article","created":{"date-parts":[[2013,2,2]],"date-time":"2013-02-02T06:31:26Z","timestamp":1359786686000},"page":"741-748","source":"Crossref","is-referenced-by-count":23,"title":["Circulating prolactin levels and risk of epithelial ovarian cancer"],"prefix":"10.1007","volume":"24","author":[{"given":"Tess V.","family":"Clendenen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A.","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Lokshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Hallmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Idahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Krogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annekatrin","family":"Lukanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Marrangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Muti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Nolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Ohlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy E.","family":"Shore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Sieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Zeleniuch-Jacquotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,3]]},"reference":[{"issue":"4","key":"156_CR1","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"Freeman ME et al (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80(4):1523\u20131631","journal-title":"Physiol Rev"},{"issue":"5","key":"156_CR2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1530\/REP-10-0033","volume":"140","author":"M Egli","year":"2010","unstructured":"Egli M, Leeners B, Kruger TH (2010) Prolactin secretion patterns: basic mechanisms and clinical implications for reproduction. Reproduction 140(5):643\u2013654","journal-title":"Reproduction"},{"issue":"4","key":"156_CR3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1095\/biolreprod.108.070003","volume":"79","author":"R Shao","year":"2008","unstructured":"Shao R et al (2008) Differences in prolactin receptor (PRLR) in mouse and human fallopian tubes: evidence for multiple regulatory mechanisms controlling PRLR isoform expression in mice. Biol Reprod 79(4):748\u2013757","journal-title":"Biol Reprod"},{"issue":"4","key":"156_CR4","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0015-0282(97)00320-8","volume":"68","author":"P Schwarzler","year":"1997","unstructured":"Schwarzler P et al (1997) Prolactin gene expression and prolactin protein in premenopausal and postmenopausal human ovaries. Fertil Steril 68(4):696\u2013701","journal-title":"Fertil Steril"},{"issue":"1","key":"156_CR5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2011.06.014","volume":"310","author":"D Tan","year":"2011","unstructured":"Tan D et al (2011) Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists. Cancer Lett 310(1):101\u2013108","journal-title":"Cancer Lett"},{"issue":"12","key":"156_CR6","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1158\/0008-5472.CAN-08-4652","volume":"69","author":"VV Levina","year":"2009","unstructured":"Levina VV et al (2009) Biological significance of prolactin in gynecologic cancers. Cancer Res 69(12):5226\u20135233","journal-title":"Cancer Res"},{"issue":"1","key":"156_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1095\/biolreprod33.1.247","volume":"33","author":"HO Osterholzer","year":"1985","unstructured":"Osterholzer HO, Streibel EJ, Nicosia SV (1985) Growth effects of protein hormones on cultured rabbit ovarian surface epithelial cells. Biol Reprod 33(1):247\u2013258","journal-title":"Biol Reprod"},{"issue":"4","key":"156_CR8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ijc.20810","volume":"115","author":"M Asai-Sato","year":"2005","unstructured":"Asai-Sato M et al (2005) Prolactin inhibits apoptosis of ovarian carcinoma cells induced by serum starvation or cisplatin treatment. Int J Cancer 115(4):539\u2013544","journal-title":"Int J Cancer"},{"issue":"10","key":"156_CR9","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.psyneuen.2011.04.007","volume":"36","author":"AK Lennartsson","year":"2011","unstructured":"Lennartsson AK, Jonsdottir IH (2011) Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology 36(10):1530\u20131539","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"156_CR10","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-08-2966","volume":"15","author":"JW Lee","year":"2009","unstructured":"Lee JW et al (2009) Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 15(8):2695\u20132702","journal-title":"Clin Cancer Res"},{"issue":"8","key":"156_CR11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"Thaker PH et al (2006) Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12(8):939\u2013944","journal-title":"Nat Med"},{"issue":"1","key":"156_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000010133","volume":"48","author":"G Gregoriou","year":"1999","unstructured":"Gregoriou G et al (1999) Evaluation of serum prolactin levels in patients with endometriosis and infertility. Gynecol Obstet Invest 48(1):48\u201351","journal-title":"Gynecol Obstet Invest"},{"issue":"7","key":"156_CR13","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/ijc.22482","volume":"120","author":"AH Eliassen","year":"2007","unstructured":"Eliassen AH, Tworoger SS, Hankinson SE (2007) Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women. Int J Cancer 120(7):1536\u20131541","journal-title":"Int J Cancer"},{"issue":"21","key":"156_CR14","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1073\/pnas.0502178102","volume":"102","author":"G Mor","year":"2005","unstructured":"Mor G et al (2005) Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci USA 102(21):7677\u20137682","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"156_CR15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ygyno.2011.05.039","volume":"122","author":"D Lu","year":"2011","unstructured":"Lu D et al (2011) Comparison of candidate serologic markers for type I and type II ovarian cancer. Gynecol Oncol 122(3):560\u2013566","journal-title":"Gynecol Oncol"},{"issue":"5","key":"156_CR16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1158\/1055-9965.EPI-10-1180","volume":"20","author":"TV Clendenen","year":"2011","unstructured":"Clendenen TV et al (2011) Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 20(5):799\u2013810","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"156_CR17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00401706.1983.10487848","volume":"25","author":"B Rosner","year":"1983","unstructured":"Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25(2):165\u2013172","journal-title":"Technometrics"},{"issue":"3","key":"156_CR18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","volume":"16","author":"S Buuren van","year":"2007","unstructured":"van Buuren S (2007) Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16(3):219\u2013242","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"156_CR19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1479-828X.2011.01321.x","volume":"51","author":"MJ Tanner","year":"2011","unstructured":"Tanner MJ, Hadlow NC, Wardrop R (2011) Variation of female prolactin levels with menopausal status and phase of menstrual cycle. Aust N Z J Obstet Gynaecol 51(4):321\u2013324","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"7","key":"156_CR20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.bjc.6605844","volume":"103","author":"JM Faupel-Badger","year":"2010","unstructured":"Faupel-Badger JM et al (2010) Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland. Br J Cancer 103(7):1097\u20131102","journal-title":"Br J Cancer"},{"issue":"5","key":"156_CR21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9378(77)90097-7","volume":"129","author":"FI Reyes","year":"1977","unstructured":"Reyes FI, Winter JS, Faiman C (1977) Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol 129(5):557\u2013564","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"156_CR22","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/1097-0142(19910915)68:6<1401::AID-CNCR2820680637>3.0.CO;2-K","volume":"68","author":"RR Love","year":"1991","unstructured":"Love RR et al (1991) Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer. Cancer 68(6):1401\u20131405","journal-title":"Cancer"},{"issue":"3","key":"156_CR23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jnci\/77.3.613","volume":"77","author":"F Meyer","year":"1986","unstructured":"Meyer F et al (1986) Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Natl Cancer Inst 77(3):613\u2013616","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"156_CR24","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/bjc.1981.121","volume":"43","author":"MC Yu","year":"1981","unstructured":"Yu MC et al (1981) Elevated levels of prolactin in nulliparous women. Br J Cancer 43(6):826\u2013831","journal-title":"Br J Cancer"},{"issue":"4","key":"156_CR25","first-page":"741","volume":"74","author":"L Bernstein","year":"1985","unstructured":"Bernstein L et al (1985) Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 74(4):741\u2013745","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"156_CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ijc.2910280106","volume":"28","author":"HG Kwa","year":"1981","unstructured":"Kwa HG et al (1981) Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birth. Int J Cancer 28(1):31\u201334","journal-title":"Int J Cancer"},{"issue":"7","key":"156_CR27","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/0277-5379(88)90132-0","volume":"24","author":"DY Wang","year":"1988","unstructured":"Wang DY et al (1988) The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. Eur J Cancer Clin Oncol 24(7):1225\u20131231","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"5","key":"156_CR28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ijc.2910330513","volume":"33","author":"DY Wang","year":"1984","unstructured":"Wang DY et al (1984) Nyctohemeral changes in plasma prolactin levels and their relationship to breast cancer risk. Int J Cancer 33(5):629\u2013632","journal-title":"Int J Cancer"},{"issue":"4","key":"156_CR29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10552-011-9731-x","volume":"22","author":"C Nagata","year":"2011","unstructured":"Nagata C et al (2011) Associations of body size and reproductive factors with circulating levels of sex hormones and prolactin in premenopausal Japanese women. Cancer Causes Control 22(4):581\u2013588","journal-title":"Cancer Causes Control"},{"issue":"5","key":"156_CR30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM198701293160501","volume":"316","author":"VC Musey","year":"1987","unstructured":"Musey VC et al (1987) Long-term effect of a first pregnancy on the secretion of prolactin. N Engl J Med 316(5):229\u2013234","journal-title":"N Engl J Med"},{"issue":"10","key":"156_CR31","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0277-5379(87)90098-8","volume":"23","author":"DY Wang","year":"1987","unstructured":"Wang DY et al (1987) The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. Eur J Cancer Clin Oncol 23(10):1541\u20131548","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"12","key":"156_CR32","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0277-5379(85)90251-2","volume":"21","author":"RR Love","year":"1985","unstructured":"Love RR, Rose DP (1985) Elevated bioactive prolactin in women at risk for familial breast cancer. Eur J Cancer Clin Oncol 21(12):1553\u20131554","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"1","key":"156_CR33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1210\/jcem-53-1-179","volume":"53","author":"PA Levin","year":"1981","unstructured":"Levin PA, Malarkey WB (1981) Daughters of women with breast cancer have elevated mean 24-hour prolactin (PRL) levels and a partial resistance of PRL to dopamine suppression. J Clin Endocrinol Metab 53(1):179\u2013183","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"156_CR34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJM197510162931602","volume":"293","author":"BR Henderson","year":"1975","unstructured":"Henderson BR et al (1975) Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. N Engl J Med 293(16):790\u2013795","journal-title":"N Engl J Med"},{"issue":"8","key":"156_CR35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5694\/j.1326-5377.1990.tb126153.x","volume":"153","author":"DM Ingram","year":"1990","unstructured":"Ingram DM, Nottage EM, Roberts AN (1990) Prolactin and breast cancer risk. Med J Aust 153(8):469\u2013473","journal-title":"Med J Aust"},{"issue":"4","key":"156_CR36","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00008469-199708000-00004","volume":"6","author":"HC Jernstrom","year":"1997","unstructured":"Jernstrom HC, Olsson H, Borg A (1997) Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19\u201325\u00a0years who were first and\/or second degree relatives to breast cancer patients. Eur J Cancer Prev 6(4):330\u2013340","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"156_CR37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000225398","volume":"37","author":"F Waard de","year":"1980","unstructured":"de Waard F, Kwa HG, Poortman J (1980) Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment. Oncology 37(1):33\u201336","journal-title":"Oncology"},{"issue":"11 Pt 2","key":"156_CR38","first-page":"4006","volume":"38","author":"J Fishman","year":"1978","unstructured":"Fishman J et al (1978) Plasma hormone profiles of young women at risk for familial breast cancer. Cancer Res 38(11 Pt 2):4006\u20134011","journal-title":"Cancer Res"},{"issue":"3","key":"156_CR39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00051793","volume":"6","author":"SE Hankinson","year":"1995","unstructured":"Hankinson SE et al (1995) Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses\u2019 Health Study (United States). Cancer Causes Control 6(3):217\u2013224","journal-title":"Cancer Causes Control"},{"key":"156_CR40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2011.06096.x","volume":"1229","author":"AE Harvey","year":"2011","unstructured":"Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 1229:45\u201352","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"156_CR41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mce.2011.05.004","volume":"356","author":"J Bouilly","year":"2012","unstructured":"Bouilly J et al (2012) Prolactin signaling mechanisms in ovary. Mol Cell Endocrinol 356(1\u20132):80\u201387","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"156_CR42","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/BF03348932","volume":"16","author":"T Hoffmann","year":"1993","unstructured":"Hoffmann T, Penel C, Ronin C (1993) Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance. J Endocrinol Invest 16(10):807\u2013816","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"156_CR43","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/edrv-16-3-354","volume":"16","author":"YN Sinha","year":"1995","unstructured":"Sinha YN (1995) Structural variants of prolactin: occurrence and physiological significance. Endocr Rev 16(3):354\u2013369","journal-title":"Endocr Rev"},{"issue":"8","key":"156_CR44","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1158\/1055-9965.EPI-08-0103","volume":"17","author":"AA Arslan","year":"2008","unstructured":"Arslan AA et al (2008) Reproducibility of serum pituitary hormones in women. Cancer Epidemiol Biomarkers Prev 17(8):1880\u20131883","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"156_CR45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1210\/jc.83.3.761","volume":"83","author":"L Katznelson","year":"1998","unstructured":"Katznelson L et al (1998) Prolactin pulsatile characteristics in postmenopausal women. J Clin Endocrinol Metab 83(3):761\u2013764","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"156_CR46","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1158\/1055-9965.EPI-06-0701","volume":"16","author":"SS Tworoger","year":"2007","unstructured":"Tworoger SS et al (2007) Effect of a 12-month randomized clinical trial of exercise on serum prolactin concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 16(5):895\u2013899","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"156_CR47","first-page":"71","volume":"76","author":"VY Fujimoto","year":"1990","unstructured":"Fujimoto VY et al (1990) Variability of serum prolactin and progesterone levels in normal women: the relevance of single hormone measurements in the clinical setting. Obstet Gynecol 76(1):71\u201378","journal-title":"Obstet Gynecol"},{"issue":"5","key":"156_CR48","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1055-9965.EPI-05-0848","volume":"15","author":"SA Missmer","year":"2006","unstructured":"Missmer SA et al (2006) Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev 15(5):972\u2013978","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"156_CR49","first-page":"917","volume":"5","author":"P Muti","year":"1996","unstructured":"Muti P et al (1996) Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 5(11):917\u2013922","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"156_CR50","first-page":"411","volume":"2","author":"KL Koenig","year":"1993","unstructured":"Koenig KL et al (1993) Reliability of serum prolactin measurements in women. Cancer Epidemiol Biomarkers Prev 2(5):411\u2013414","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"156_CR51","first-page":"649","volume":"4","author":"SE Hankinson","year":"1995","unstructured":"Hankinson SE et al (1995) Reproducibility of plasma hormone levels in postmenopausal women over a 2\u20133-year period. Cancer Epidemiol Biomarkers Prev 4(6):649\u2013654","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0156-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-013-0156-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0156-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T17:22:06Z","timestamp":1595352126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-013-0156-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,3]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["156"],"URL":"https:\/\/doi.org\/10.1007\/s10552-013-0156-6","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,3]]}}}